CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
about
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioidsIs lipid signaling through cannabinoid 2 receptors part of a protective system?The endocannabinoid system as an emerging target of pharmacotherapySpecies-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersNovel cannabinoid receptorsActions of N-arachidonyl-glycine in a rat inflammatory pain modelβ-caryophyllene and β-caryophyllene oxide-natural compounds of anticancer and analgesic propertiesTargeting cannabinoid agonists for inflammatory and neuropathic painSynthesis and pharmacology of 1-methoxy analogs of CP-47,497.Treatment with a cannabinoid receptor 2 agonist decreases severity of established cystitis1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.Gait analysis in rats with single joint inflammation: influence of experimental factors.The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.Therapeutic potential of cannabinoid receptor agonists as analgesic agents.Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.The endocannabinoid system: current pharmacological research and therapeutic possibilities.Evaluation of fatty acid amides in the carrageenan-induced paw edema model.Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.Endocannabinoid mechanisms of pain modulationActivation of cannabinoid receptor 2 inhibits experimental cystitisModulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.Modulating the endocannabinoid system in human health and disease--successes and failuresInhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airwaysCannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.The analgesic potential of cannabinoids.The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of C-fiber nociceptors in a murine model of cancer painMetabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.Novel ω-conotoxins from C. catus reverse signs of mouse inflammatory pain after systemic administration.Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.Dynamic regulation of the endocannabinoid system: implications for analgesia.Natural products evaluated in neuropathic pain models - a systematic review.Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.
P2860
Q24556619-5D497AB9-3841-4EDD-927D-D868E62C0FA0Q24633122-99BAE2B9-E569-4360-927F-D813D4F367FFQ24648473-534FC45C-F3F0-4DFF-99E6-0207F280E4A9Q24673335-29BE1034-C81E-4C2D-AE54-9461E4AC5AA4Q24681482-733C3BA9-2946-4C25-B054-874380978F6FQ27498684-61AA730A-E26A-4E7D-868A-2A29F208C16CQ28078891-20E49F5A-3496-4395-97DD-669D327BCE0AQ28307619-38F12205-0BFE-4563-9C22-E6BA1007CBC3Q34059803-D730E53D-F6BB-41A0-840F-73EAEBC14BA5Q34176058-6603E2A7-A61E-4C65-941A-A4BC3A374A32Q34298682-06959B2A-3D25-4759-9C51-12E27E6353C7Q34446967-745D5C9D-A08F-4224-AA31-2527A65E7D1BQ34496064-E42D78D4-3D26-4776-B56E-A5A87B8FCE43Q35545219-CC124ECC-092E-4E44-A74F-5760C75FA996Q36015427-D58E04C2-8790-4476-9E2E-8F5651194279Q36187065-345EB954-F21D-4866-ACA5-070C0234F592Q36224483-8C967B0D-8484-495C-8A42-787F7E5D12C0Q36341688-AF14AEA7-D69C-4C4B-AE2C-DFD1433BCBC5Q36381416-47806AF5-4CD2-4F60-922F-E977A3DB0AAFQ36384547-822E9B66-54F4-4504-8166-8C387ED14B0BQ36488601-AB639DEF-EC88-4D5C-821A-6FF8776DD226Q36711160-3FDC9FF4-1139-429B-BD83-E9F59B943564Q36838206-98817A6F-B1F6-4793-AE03-2AAFD9D2C0E3Q36843205-D051B5C7-51F0-41BF-BB57-E896ED70B6ACQ36912778-62D15462-E805-4A72-B9BD-E2E17EFB87CDQ36933683-6069ABC0-AD25-42CF-A6AA-8B840E5EDA03Q36964922-124B92E2-5290-432D-9CDF-249CA0D7FEBFQ36997712-97E2069C-B1DC-4DA6-A6EA-96BE93FE5511Q37057325-E0E84FD8-7118-4421-8E70-738450169E1FQ37120771-9C3E5626-ADDB-43BA-ABD3-61EAC975886FQ37211788-A6BC9ABF-9137-4358-B60B-AA9F7D7C5801Q37312874-7F0C24DD-1CC6-4B7E-B83A-257717D135C8Q37369881-1FD5F495-8F8B-4747-8615-B3BF729A1A88Q37371095-D3593BF2-34C5-41D7-8EEF-BA367050E343Q37611106-73DF0145-B121-4CC0-9AF9-466FADCC24D6Q38164130-F46929D1-33F3-4F52-A7D8-5B9BD221D44EQ38185071-9DA44108-5136-4077-9AA1-1474FC9A380EQ38185075-2915CCEB-5DE3-40FD-8CDA-E17D501901A3Q38287127-75745866-C886-4222-A579-57FBBFAC01A3Q38600704-546A969C-3F49-4932-9E90-C36245086AB6
P2860
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@ast
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@en
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@nl
type
label
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@ast
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@en
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@nl
prefLabel
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@ast
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@en
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@nl
P2093
P921
P1433
P1476
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
@en
P2093
C T O'Shaughnessy
F H Marshall
P304
P356
10.1016/S0304-3959(01)00454-7
P407
P577
2002-04-01T00:00:00Z